Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Primary objectives for rivaroxaban randomization: •To determine whether rivaroxaban 2.5 mg twice daily (bid) + aspirin 100 mg once daily (od) compared with aspirin 100 mg od reduces the risk of a composite of myocardial infarction, stroke, or cardiovascular death in subjects with CAD or PAD •To determine whether rivaroxaban 5 mg bid compared with aspirin 100 mg od reduces the risk of a composite of myocardial infarction, stroke or cardiovascular death in subjects with CAD or PAD
Critère d'inclusion
- Prevention of major cardiovascular events in patients with coronary or peripheral artery disease